Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
Dan JiaChunliang LiuZhenyu ZhuYan CaoWen WenZhanying HongYue LiuErdong LiuLong ChenChun ChenYanqiu GuBinghua JiaoYifeng ChaiHong-Yang WangJing FuXiaofei ChenPublished in: Clinical and translational medicine (2022)
These results uncover a unique role for oroxylin A in TKT inhibition, which directly targets TKT and suppresses the non-oxidative PPP. Our findings will facilitate the development of small-molecule inhibitors of TKT and novel therapeutics for HCC.